Alcon Inc. (NYSE:ALC) Q3 2023 Earnings Call Transcript

Jeff Johnson: Thank you.

Operator: Thank you. Our next question is from Graham Doyle with UBS. Please proceed with your question.

Graham Doyle: Hi guys, thanks for taking my questions. Just a quick one and then a slightly longer one. On the quick one, so could you just confirm, we did hear that right, so US IOLs as a market grew 2% and you’re completely, you’ve been taking share there or at least maintaining in Q3, so it’s like a sequential improvement over Q2. And then maybe Tim, just one on the guidance range for this year in terms of core EBIT margin, obviously still pretty wide as we go into the last quarter, is — it was kind of unusual, is that a reflection of the fact that you’ve got this kind of stronger contact lens margin or Vision Care margin at Q4, and therefore maybe it’s a slightly different mix potential than usual, is that what gives you kind of hope that there’s upside in terms of where we stand today? Thank you.

David Endicott: Yeah, Graham, total procedures in the market grew roughly 3%, 2%, depending on how you want to round it. Internationally, it grew a little faster than that, and the globe grew about 4%, But most of the international growth was in emerging markets, I would just tell you. So again, and relative to our performance in market in the US, we saw monofocal share grow, we saw PCIOL share grow, we saw torque decline, those are all year-over-year, but sequentially torics improved. So I would just say overall our total share grew and again I think in the US we had a pretty solid performance and pretty much as expected. I just remind you, people try things in this market because it’s a discrete opportunity to do that, but they generally come back to the products that they think are the best performing products.

Tim Stonesifer: Yeah, and then I would just say on the margin, it’s really going to be volume driven and mix to your point. It really just depends on, we’ve always said that we sort of pick the midpoint, so I’d probably stick with that. But it could be plus or minus depending on what the final revenue and volume numbers look like.

Graham Doyle: That’s great. Thanks a lot guys. Appreciate it.

Operator: Thank you. There are no further questions at this time. I’d like to hand the floor back over to Dan Cravens for any closing comments.

Dan Cravens : Well, thanks, everybody, for joining us. If you have any follow-up questions, certainly feel free to reach out to Allen Trang and myself in Investor Relations or for media, reach out to our Media Relations team. Thanks again. Have a great day.

Operator: This concludes today’s conference. You may disconnect your lines at this time. Thank you for your participation.